Sutilains

舒替兰酶

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSutilains
Drug Alias Name枯草杆菌蛋白酶Travase
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsBurnsWounds and InjuriesUlcer
Global Approved IndicationsBurnsWounds and InjuriesUlcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1969/06/12
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsBurnsWounds and InjuriesUlcer

Other Information

ATC CodeD03BA
Related LinksDrugBankKEGG